APOA5

The need for an advanced understanding of lipidology structure and function in healthcare is growing.   Lipoprotein testing provides valuable insights into an individual's lipid profile, aiding in the assessment of cardiovascular risk and guiding interventions above and beyond the standard lipid panel.  

Apolipoprotein ApoA5 plays a pivotal role in hepatic lipid metabolism, a major determinant of cardiometabolic health.  Specifically, ApoA5 targets triglyceride metabolism in the liver, highlighting its connections with metabolic syndrome.  

Dysregulation of ApoA5 levels has been implicated in various cardiometabolic diseases including obesity, nonalcoholic fatty liver disease (NAFLD), and metabolic syndrome.  [3., 14.]

In this article, we explore the function and clinical significance of ApoA5 as well as dietary, lifestyle, and supplement interventions to optimize cardiometabolic health. Additionally, we provide insights into lipoprotein testing options to assess cardiovascular risk.

Understanding ApoA5

What is ApoA5?

Lipoproteins are soluble proteins that can transport lipids throughout the body.

Apolipoprotein A5 (ApoA5) is a lipoprotein synthesized solely in the liver, and it is found in low concentrations in the bloodstream. 

ApoA5 enhances triglyceride and lipoprotein remnant clearance, in part in the liver.  As such, it may be a key biomarker connecting hepatic lipid and glucose metabolism.  

It may also have effects on adipocytes, although its exact roles and mechanism of action is still being elucidated.  [14.]  

Studies have demonstrated correlations between overexpression of the ApoA5 gene and markedly lower plasma triglyceride levels, as well as the opposite: decreased expression of the ApoA5 gene is associated with as much as four times greater plasma triglyceride levels than control groups.  [14.]

Functions of ApoA5 in Triglyceride Metabolism and Cardiovascular Health  [5., 6., 12., 14., 18.]

The actions of ApoA5 are generally understood according to their extracellular and intracellular properties.  

Extracellular Functions of ApoA5

Despite its low concentration in plasma compared to apoA1, apoA5 exhibits significant influence over plasma triglyceride (TG) levels. 

Research indicates that knockdown of the APOA5 gene in mice dramatically increases plasma TG levels, while overexpression of the human APOA5 gene leads to a significant reduction. Human genetic studies have also identified several APOA5 single nucleotide polymorphisms (SNPs) associated with plasma TG levels.  [14.] 

ApoA5 directly stimulates lipoprotein lipase (LPL)-mediated hydrolysis of triglycerides, enhancing the removal of triglyceride-rich lipoproteins (TRLs) and their remnants from the bloodstream. Moreover, apoA5 enhances hepatic uptake of TRLs by interacting with members of the LDL receptor (LDLR) family.  [14.]  

Intracellular Functions of ApoA5

ApoA5 demonstrates significant intracellular effects on lipid storage, particularly in hepatocytes and adipocytes.

While a fraction of hepatic-derived apoA5 is secreted into plasma to facilitate triglyceride hydrolysis by lipoprotein lipase (LPL), another portion of apoA5 is retained intracellularly, associating with cytosolic lipid droplets (LDs).  [3.]

Within hepatocytes, ApoA5 modulates triglyceride secretion and VLDL particle formation, and reduces the production of triglyceride-rich VLDL that will enter circulation. Moreover, ApoA5's intracellular presence suggests a role akin to other intracellular proteins that regulate lipid metabolism. 

In adipocytes, ApoA5 internalization occurs through LDL receptor family members, influencing LD-associated intracellular protein expression and triglyceride storage. 

ApoA5-treated adipocytes exhibit enhanced lipolysis activity and increased expression of uncoupling protein 1 (UCP1).  ApoA5 significantly reduces intracellular triglyceride content.  These functions implicate a role for ApoA5 in energy expenditure and thermogenesis. [14.] 

Additionally, ApoA5's ability to regulate adipocyte differentiation suggests a potential role in mitigating excessive adipogenesis and adipocyte hypertrophy, thus presenting a promising target for managing obesity-related metabolic disorders.

Clinical Significance of ApoA5 

The clinical significance of understanding particular ApoA5 SNPs present lies in its association with plasma triglyceride levels and the risk of cardiovascular disease. 

The two main mechanisms currently understood to give ApoA5 its triglyceride-lowering capacity are: (1) ApoA5 enhances the catabolism of TG-rich lipoproteins by lipoprotein lipase (LPL), and (2) it inhibits the production rate of very low-density lipoprotein (VLDL).  [5.]

While this is currently the consensus, some earlier studies have correlated elevated levels of APoA5 with elevated triglyceride levels, including in patients with diabetes.  [2., 15.]  This may be due at least in part to altered function of LPL, which can occur in diabetes.  [16.]

ApoA5 Testing Options

Overview of ApoA5 Testing

ApoA5 testing involves assessing the levels of apolipoprotein A5 (ApoA5) in the bloodstream, typically through blood serum or plasma samples.  Venipuncture is commonly required.  This test is commonly done in research settings.  

Genetic testing to identify genetic polymorphisms of ApoA5 are also available.  

More commonly,  apolipoprotein testing including testing for ApoA1, ApoB, and ApoE, is available to provide additional insight into an individual’s cardiovascular risk profile.  

Natural Ways to Optimize ApoA5 Levels

Diet and lifestyle are the mainstays of good cardiometabolic health.  Certain supplements and medications may also be considered under the guidance of a licensed healthcare practitioner.  

Dietary Strategies

Diets Containing Fermented Dairy Products: diets containing fermented dairy products have been shown to promote healthy lipid outcomes and increase ApoA1 levels in particular.  [4., 9.]  

Foods Rich in Omega-3 Fatty Acids: Fatty fish (salmon, mackerel, sardines), flaxseeds, chia seeds, walnuts all have scientific evidence of efficacy in improving lipoprotein profiles and reducing cardiovascular disease risk.  [4., 9.]

‍Fiber-Rich Foods: Whole grains (oats, barley, quinoa), fruits (apples, berries, oranges), vegetables (broccoli, Brussels sprouts, carrots), legumes (beans, lentils) are all Mediterranean diet staples that have shown effectiveness in reducing cardiovascular disease risk.  [9.]

Avoid excess sugar: diets high in sugar are highly correlated with poor cardiometabolic health outcomes, as well as elevated triglycerides.  [4.]

Lifestyle Modifications

Regular Exercise: Aerobic activities (walking, jogging, swimming), strength training, yoga, tai chi may all promote cardiovascular health.  [4., 17.]

Smoking Cessation: Quitting smoking reduces oxidative stress and inflammation, contributing to improved lipid profiles.  [4.]

Stress Management: Techniques such as meditation, deep breathing exercises, yoga, and mindfulness may help lower stress levels and improve overall cardiovascular health,and in some cases may also have a positive effect on lipid profiles.  [11.]

Supplement and Medication Options 

Individuals should speak with their healthcare provider prior to initiating any supplement or medication therapies. 

Fibrates: fibrates are a class of medications known to decrease triglyceride levels; research indicates that one mechanism of action may be ApoA5 upregulation.  [14.]

‍Niacin (Vitamin B3): Niacin supplementation has been shown to improve HDL cholesterol and triglyceride levels.  [1., 8.]

Fish Oil: fish oil has been shown to reduce triglyceride levels and stimulate LPL activity.  [13.]

Order Lipoprotein Tests

Click here to compare and order tests for lipoprotein levels.